Drug can improve memory in Down syndrome patients, researchers say
A long-anticipated CU study claims an Alzheimer’s drug can boost memory function in Down syndrome patients, researchers announced Tuesday.
CU School of Medicine researchers said the drug memantine improved “visual episodic memory,” such as retaining long lists of vocabulary words, in Down syndrome patients. The 16-week course compared the results to a control group taking only a placebo.
The study did not find improvement in two other areas of thinking, adaptive or most areas of cognitive ability.